文献速递腹部技术与安全US

超声脂肪肝指标:区分脂肪变性与非酒精性脂肪性肝炎的简易工具:在普通肥胖人群中的有效性

Ultrasound Fatty Liver Indicator: A Simple Tool for Differentiating Steatosis From Nonalcoholic Steatohepatitis: Validity in the Average Obese Population.
PubMed 文献 · J Ultrasound Med · 2019-10-24

回顾性分析208例肝脏正常、脂肪变性及非酒精性脂肪性肝炎(NASH)患者的超声特征,评估超声脂肪肝指标(US-FLI)区分脂肪变性与NASH的价值。胆囊壁显示困难和血管模糊在脂肪变性与NASH组间有差异,血管模糊是NASH的唯一超声预测因子,但US-FLI评分≥5时区分脂肪变性与NASH的AUC仅0.649,性能不佳。US-FLI评分≤4提示无NASH(阴性预测值88%,敏感度91%)。

要点

  • 血管模糊对NASH敏感度93%,胆囊壁显示困难对NASH特异度89%。
  • US-FLI评分≤4提示无NASH,阴性预测值88%、敏感度91%。
  • US-FLI评分≥5时区分脂肪变性与NASH的AUC为0.649,性能不佳。

核心结论

  • US-FLI可能区分普通肥胖人群中的脂肪变性与NASH,血管模糊和胆囊壁显示困难是最重要指标,联合US-FLI评分与血管模糊可提高NASH识别。

研究设计与样本

  • 回顾性分析208例患者,肝脏正常14例、脂肪变性89例、NASH 105例,排除肝胆疾病及饮酒史,评估肝脏-肾脏对比、后方衰减、血管模糊、胆囊壁显示困难、膈肌显示困难及局灶性脂肪保留等超声指标。

关键影像表现/征象

  • 胆囊壁显示困难与血管模糊在脂肪变性组与NASH组间不同(P≤.01)。
  • 胆囊壁显示困难对NASH特异度89%,血管模糊对NASH敏感度93%。
  • 局灶性脂肪保留等其余超声指标未报告组间差异。

诊断标准与关键数值

  • US-FLI评分≤4提示无NASH,阴性预测值88%、敏感度91%。
  • US-FLI评分≥5区分脂肪变性与NASH的AUC为0.649。
  • 血管模糊是NASH的唯一超声独立预测因子(P≤.01)。

临床应用与阅片要点

  • 阅片时关注血管模糊(对NASH敏感度93%)和胆囊壁显示困难(对NASH特异度89%)。
  • US-FLI评分≤4时提示无NASH(阴性预测值88%)。
  • US-FLI评分≥5时区分脂肪变性与NASH的AUC仅0.649,性能不佳。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Steatosis, nonalcoholic steatohepatitis (NASH), and fibrosis/cirrhosis represent a spectrum of fatty liver disease. The ultrasound fatty liver indicator (US-FLI) evaluates ultrasound (US) features to identify stages of fatty liver disease. We hypothesized that US features could be independent predictors of NASH and that the US-FLI differentiates steatosis from NASH in the average obese population.

METHODS: A retrospective analysis of 208 patients with normal (n = 14), steatotic (n = 89), and NASH (n = 105) livers was performed. Liver/biliary disease and a history of alcohol intake were excluded. Ultrasound metrics included liver-kidney contrast, posterior attenuation, vessel blurring, difficulty visualizing the gallbladder wall, difficulty visualizing the diaphragm, and areas of focal fatty sparing. A statistical comparison of the 3 groups as well as fibrosis stage I and II/III NASH groups was performed. Logistic regression identified independent predictors of NASH.

RESULTS: Gallbladder wall visualization and vessel blurring were different between the steatosis and NASH groups (P ≤ .01). Gallbladder wall visualization was specific for NASH (89%), and vessel blurring was sensitive for NASH (93%). A US-FLI score of 4 or lower suggested the absence of NASH (negative predictive value, 88%; sensitivity, 91%). Logistic regression revealed vessel blurring as the only US predictor of NASH (P ≤ .01). However, the area under the curve (0.649) showed poor performance in differentiating steatosis from NASH when the US-FLI score was 5 or higher.

CONCLUSIONS: Our data suggest that the US-FLI may differentiate steatosis from NASH in the average obese population. Vessel blurring and poor gallbladder wall visualization were the most important metrics. Identification of NASH was enhanced by including the US-FLI score with vessel blurring.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Nelson SM, Hoskins JD, Lisanti C, et al. Ultrasound Fatty Liver Indicator: A Simple Tool for Differentiating Steatosis From Nonalcoholic Steatohepatitis: Validity in the Average Obese Population. J Ultrasound Med. 2019. PMID: 31647137. doi:10.1002/jum.15154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。